Status: current, Defined. Date: 31-Oct 2013. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3750241000168115 | Sevikar HCT 20/5/12.5 (amlodipine 5 mg + hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3750251000168118 | Sevikar HCT 20/5/12.5 tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Sevikar HCT 20/5/12.5 tablet, 30, blister pack | has TPUU | True | Sevikar HCT 20/5/12.5 tablet | Inferred relationship | Some | 1 |
Sevikar HCT 20/5/12.5 tablet, 10, blister pack | has TPUU | True | Sevikar HCT 20/5/12.5 tablet | Inferred relationship | Some | 1 |
Sevikar HCT 20/5/12.5 tablet, 30 | has TPUU | True | Sevikar HCT 20/5/12.5 tablet | Inferred relationship | Some | 1 |
Sevikar HCT 20/5/12.5 tablet, 10 | has TPUU | True | Sevikar HCT 20/5/12.5 tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set